Patient characteristics and previous treatment
Patients | Presentation* | Previous systemic treatment | Duration of disease (years) | Patient | Presentation* | Previous systemic treatment | Duration of disease (years) |
---|---|---|---|---|---|---|---|
*OA, oral aphthous lesions: 6/6; | |||||||
V, vasculitis in a skin biopsy: 0/6; | |||||||
GU, genital ulcerations: 6/6; | |||||||
C, colitis/gastrointestinal vasculitis: 1/6; | |||||||
A, arthralgia/arthritis (usually a non-symmetric arthritis): 6/6; | |||||||
TF, thrombophlebitis: 2/6; | |||||||
SL, skin lesions: 3/6; | |||||||
BU, bilateral panuveitis (severe panuveitis): 6/6. | |||||||
Behçet’s disease: n = 6, mean age: 44, range 32–66 | |||||||
Patient 1, M; 38 years, Behçet’s disease | OA + GU, A, TF, BU | Cyclosporine, colchicine, interferon alfa, prednisone | 6 | Patient 4, M; 56 years, Behçet’s disease | OA + GU, A, SL, BU | Cyclosporine, colchicine, azathioprine | 22 |
Patient 2, M; 32 years, Behçet’s disease | OA + GU, A, SL; C, BU | Azathioprine, interferon alfa | 10 | Patient 5, M; 34 years, Behçet’s disease | OA + GU, A BU | Interferon alfa | 15 |
Patient 3, F; 37 years, Behçet’s disease | OA + GU, A, TF, SL, BU | Cyclosporine, colchicine, interferon alfa | 6 | Patient 6, M; 66 years Behçet’s disease | OA + GU A BU | Cyclosporine Interferon alfa Azathioprine, colchicine, prednisone | 7 |
Patient A, F; 31 years, idiopathic uveitis | Prednisone, MTX | 5 | Patient E, F; 38 years, idiopathic uveitis | Prednisone, cyclosporine | 4 | ||
Patient B, M; 29 years, idiopathic uveitis | Cyclosporine, prednisone, interferon alfa | 7 | Patient F, M; 39 years, sarcoidosis | Prednisone, MTX | 5 | ||
Patient C, F; 62 years, idiopathic uveitis | Prednisone, cyclosporine | 2 | Patient G, F; 60 years, birdshot | Cyclosporine, prednisone, MTX | 10 | ||
Patient D, M; 20 years, idiopathic uveitis | Cyclosporine, Cellcept, Octreotide LAR, prednisone | 8 |